We narrowed to 7,490 results for: Ank
-
Plasmid#34691DepositorAvailable SinceFeb. 1, 2012AvailabilityAcademic Institutions and Nonprofits only
-
pFLAG-TNKS-2-M1054V
Plasmid#34692DepositorAvailable SinceFeb. 1, 2012AvailabilityAcademic Institutions and Nonprofits only -
pBEG R3-miRNA(ccdB)-L4 #BGV228
Plasmid#48953PurposeTo create an AttR3-AttL4 flanked Entry vector encoding a miR30-embedded shRNA to knockdown targeted gene expression. (This corresponds to a module 4 plasmid).DepositorTypeEmpty backboneUseGateway cloning vectorPromoternaAvailable SinceJune 16, 2014AvailabilityAcademic Institutions and Nonprofits only -
pBEG R2-iCreT2ALuc-L3 #BGV208
Plasmid#48992PurposeSupplies Cre recombinase and Luciferase and IRES with flanked by AttR2 and AttL3 sites for Gateway cloning recombination reaction. (This corresponds to a module 3 plasmid).DepositorInsertscre recombinase
Luciferase
UseLuciferase; Gateway cloning vectorTagsIRES (weak)PromoterUnknownAvailable SinceJune 16, 2014AvailabilityAcademic Institutions and Nonprofits only -
pLenti-sgStuffer-GFP-Puro
Plasmid#208349PurposeLentivirus sgRNA backbone with GFP and PuroR. Compatible with golden gate cloning (Esp3i/BsmBI)DepositorArticleTypeEmpty backboneUseCRISPR and LentiviralPromoterhU6Available SinceJan. 29, 2026AvailabilityAcademic Institutions and Nonprofits only -
pLenti-sgStuffer-mCherry-Puro
Plasmid#208350PurposeLentivirus sgRNA backbone with mCherry and PuroR. Compatible with golden gate cloning (Esp3i/BsmBI)DepositorArticleTypeEmpty backboneUseCRISPR and LentiviralPromoterhU6Available SinceJan. 29, 2026AvailabilityAcademic Institutions and Nonprofits only -
FUCGW-DEST
Plasmid#208408PurposeLentivirus compatible with LR Gateway cloning for UBC-driven gene expression with CMV-GFP in backboneDepositorArticleTypeEmpty backboneUseLentiviral; Gateway: dest vectorPromoterUBCAvailable SinceJan. 29, 2026AvailabilityAcademic Institutions and Nonprofits only -
FUCRW-DEST
Plasmid#208409PurposeLentivirus compatible with LR Gateway cloning for UBC-driven gene expression with CMV-RFP in backboneDepositorArticleTypeEmpty backboneUseLentiviral; Gateway: dest vectorPromoterUBCAvailable SinceJan. 29, 2026AvailabilityAcademic Institutions and Nonprofits only -
Self-targeting epegRNA library, +5 G>H (lDS004)
Pooled Library#227707PurposeCRISPR guide RNA library for prime editingDepositorExpressionMammalianUseLentiviralAvailable SinceJan. 23, 2025AvailabilityAcademic Institutions and Nonprofits only -
StopPR epegRNA library (lAC002)
Pooled Library#227706PurposeCRISPR guide RNA library for prime editingDepositorExpressionMammalianUseLentiviralAvailable SinceJan. 23, 2025AvailabilityAcademic Institutions and Nonprofits only -
BCAM promoter-pRB-Puro-TurboRFPmyc-T2A-Luciferase
Plasmid#188391PurposeReporter for BCAM expressionDepositorInsertBCAM reporter
UseLuciferaseAvailable SinceOct. 12, 2022AvailabilityAcademic Institutions and Nonprofits only -
pBEG R2-dsRed-L3 #BGV203
Plasmid#48973PurposeSupplies the selection marker (dsRed) and IRES with flanked by AttR2 and AttL3 sites for Gateway cloning recombination reaction. (This corresponds to a module 3 plasmid).DepositorInsertdsRed
UseGateway cloning vectorTagsIRES (strong)PromoternoneAvailable SinceJune 16, 2014AvailabilityAcademic Institutions and Nonprofits only -
pBEG R2-iBlast-L3 #BGV204
Plasmid#48982PurposeSupplies the selection marker (blasticidin resistance) and IRES with flanked by AttR2 and AttL3 sites for Gateway cloning recombination reaction. (This corresponds to a module 3 plasmid).DepositorInsertblasticidin-S deaminase
UseGateway cloning vectorTagsIRES (weak)PromoternaAvailable SinceJune 16, 2014AvailabilityAcademic Institutions and Nonprofits only -
pBEG R2-iHygro-L3 #BGV206
Plasmid#48985PurposeSupplies the selection marker (hygromycin resistance) and IRES with flanked by AttR2 and AttL3 sites for Gateway cloning recombination reaction. (This corresponds to a module 3 plasmid).DepositorInserthygromycin phosphotransferase
UseGateway cloning vectorTagsIRES (weak)PromoternaAvailable SinceJune 16, 2014AvailabilityAcademic Institutions and Nonprofits only -
pBEG R2-iPuro-L3 #BGV205
Plasmid#48987PurposeSupplies the selection marker (puromycin resistance) and IRES with flanked by AttR2 and AttL3 sites for Gateway cloning recombination reaction. (This corresponds to a module 3 plasmid).DepositorInsertpuromycin resistance
UseGateway cloning vectorTagsIRES (weak)PromoterNAAvailable SinceJune 16, 2014AvailabilityAcademic Institutions and Nonprofits only -
pBEG R2-eGFP-L3 #BGV201
Plasmid#48979PurposeSupplies the selection marker (eGFP) and IRES with flanked by AttR2 and AttL3 sites for Gateway cloning recombination reaction. (This corresponds to a module 3 plasmid).DepositorInserteGFP
UseGateway cloning vectorTagsIRES (strong)PromoterNAAvailable SinceJune 16, 2014AvailabilityAcademic Institutions and Nonprofits only -
pBEG R2-iNeo-L3 #BGV207
Plasmid#48986PurposeSupplies the selection marker (neomycin resistance) and IRES with flanked by AttR2 and AttL3 sites for Gateway cloning recombination reaction. (This corresponds to a module 3 plasmid).DepositorInsertneomycin resistance
UseGateway cloning vectorTagsIRES (weak)PromoterNAAvailable SinceJune 16, 2014AvailabilityAcademic Institutions and Nonprofits only -
pBEG R2-eCFP-L3 #BGV202
Plasmid#48977PurposeSupplies the selection marker (eCFP) and IRES with flanked by AttR2 and AttL3 sites for Gateway cloning recombination reaction. (This corresponds to a module 3 plasmid).DepositorInserteCFP
UseGateway cloning vectorTagsIRES (strong)PromoterNAAvailable SinceJune 16, 2014AvailabilityAcademic Institutions and Nonprofits only -
pHEN-CoV2-nanobody-G6
Plasmid#194589PurposeBacterial expression of G6 nanobody targeting the receptor binding domain (RBD) of SARS-CoV-2 spikeDepositorInsertG6 (S )
ExpressionBacterialAvailable SinceFeb. 1, 2023AvailabilityAcademic Institutions and Nonprofits only -
pLenti-Cas9.mCherry
Plasmid#208342PurposeLentivirus with EF1a driven Cas9 linked (P2A) to mCherry.DepositorArticleInsertsCas9
mCherry
UseCRISPR and LentiviralTagsnuclear localization sequence (NLS) and FLAG tagPromoterEF-1aAvailable SinceJan. 29, 2026AvailabilityAcademic Institutions and Nonprofits only